Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Alembic Pharmaceuticals Ltd.
NSE: APLLTD
|
BSE: 533573
|
ISIN: INE901L01018
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
720.1500
-6.10
(
-0.84
%)
NSE
Apr 09, 2026
15:31 PM
35.00% Fall from 52W High
Volume:
41,524
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alembic Pharmaceuticals Ltd.
05 Feb 2024
US FDA Approval
720.15
-0.84%
India/export formulation drive earnings
Neutral:
Alembic Pharmaceuticals Ltd.
by
Motilal Oswal
Target: 910
Target
Motilal Oswal
Alembic Pharmaceutic.. has an
average target
of 1022.00 from 4 brokers.
More from Alembic Pharmaceuticals Ltd.
Recommended
Market closes lower as Middle East tensions weaken ceasefire optimism
Trendlyne Marketwatch |
09 Apr 2026, 03:57PM
After the drop, are stock market valuations finally reasonable?
The Baseline |
09 Apr 2026, 03:18PM
Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals
|
22 Jul 2020